These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review. Solar P; Mackerle Z; Joukal M; Jancalek R Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117 [TBL] [Abstract][Full Text] [Related]
5. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study. Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123 [TBL] [Abstract][Full Text] [Related]
6. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm. Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic response and clinical outcome following intravenous milrinone plus norepinephrine-based hyperdynamic hypertensive therapy in patients suffering secondary cerebral ischemia after aneurysmal subarachnoid hemorrhage. Steiger HJ; Ensner R; Andereggen L; Remonda L; Berberat J; Marbacher S Acta Neurochir (Wien); 2022 Mar; 164(3):811-821. PubMed ID: 35138488 [TBL] [Abstract][Full Text] [Related]
14. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis. Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121 [TBL] [Abstract][Full Text] [Related]
15. Nimodipine in subarachnoid hemorrhage. DiPalma JR Am Fam Physician; 1989 Dec; 40(6):143-5. PubMed ID: 2686374 [TBL] [Abstract][Full Text] [Related]
16. The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation. Paľa A; Schneider M; Brand C; Pedro MT; Özpeynirci Y; Schmitz B; Wirtz CR; Kapapa T; König R; Braun M Neurosurg Rev; 2019 Jun; 42(2):463-469. PubMed ID: 29804157 [TBL] [Abstract][Full Text] [Related]
17. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling. Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268 [TBL] [Abstract][Full Text] [Related]
18. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Ditz C; Matone MV; Schwachenwald B; Küchler J Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859 [TBL] [Abstract][Full Text] [Related]
19. The Impact of Nimodipine Administration through Feeding Tube on Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage. Isse FA; Abdallah YEH; Mahmoud SH J Pharm Pharm Sci; 2020; 23(1):100-108. PubMed ID: 32348716 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness and feasibility of cilostazol in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Shan T; Zhang T; Qian W; Ma L; Li H; You C; Xie X J Neurol; 2020 Jun; 267(6):1577-1584. PubMed ID: 30739182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]